• Je něco špatně v tomto záznamu ?

A systematic review and meta-analysis on delaying surgery for urothelial carcinoma of bladder and upper tract urothelial carcinoma: Implications for the COVID19 pandemic and beyond

JJ. Leow, WS. Tan, WP. Tan, TW. Tan, VW. Chan, KAO. Tikkinen, A. Kamat, S. Sengupta, MV. Meng, S. Shariat, M. Roupret, K. Decaestecker, N. Vasdev, YL. Chong, D. Enikeev, G. Giannarini, V. Ficarra, JY. Teoh, UroSoMe Collaborators

. 2022 ; 9 (-) : 879774. [pub] 20221004

Status neindexováno Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc22031615

PURPOSE: The COVID-19 pandemic has led to competing strains on hospital resources and healthcare personnel. Patients with newly diagnosed invasive urothelial carcinomas of bladder (UCB) upper tract (UTUC) may experience delays to definitive radical cystectomy (RC) or radical nephro-ureterectomy (RNU) respectively. We evaluate the impact of delaying definitive surgery on survival outcomes for invasive UCB and UTUC. METHODS: We searched for all studies investigating delayed urologic cancer surgery in Medline and Embase up to June 2020. A systematic review and meta-analysis was performed. RESULTS: We identified a total of 30 studies with 32,591 patients. Across 13 studies (n = 12,201), a delay from diagnosis of bladder cancer/TURBT to RC was associated with poorer overall survival (HR 1.25, 95% CI: 1.09-1.45, p = 0.002). For patients who underwent neoadjuvant chemotherapy before RC, across the 5 studies (n = 4,316 patients), a delay between neoadjuvant chemotherapy and radical cystectomy was not found to be significantly associated with overall survival (pooled HR 1.37, 95% CI: 0.96-1.94, p = 0.08). For UTUC, 6 studies (n = 4,629) found that delay between diagnosis of UTUC to RNU was associated with poorer overall survival (pooled HR 1.55, 95% CI: 1.19-2.02, p = 0.001) and cancer-specific survival (pooled HR of 2.56, 95% CI: 1.50-4.37, p = 0.001). Limitations included between-study heterogeneity, particularly in the definitions of delay cut-off periods between diagnosis to surgery. CONCLUSIONS: A delay from diagnosis of UCB or UTUC to definitive RC or RNU was associated with poorer survival outcomes. This was not the case for patients who received neoadjuvant chemotherapy.

Department of Human and Pediatric Pathology Gaetano Barresi Urologic Section University of Messina Messina Italy

Department of Human Structure and Repair Ghent University Belgium

Department of Surgery South Karelian Central Hospital Lappeenranta Finland

Department of Urology 2nd Faculty of Medicine Charles University Prag Czech Republic

Department of Urology AZ Maria Middelares Hospital Ghent Belgium

Department of Urology Comprehensive Cancer Center Medical University of Vienna Vienna Austria

Department of Urology Ghent University Hospital Ghent Belgium

Department of Urology Hertfordshire and Bedfordshire Urological Cancer Centre Lister Hospital Stevenage School of Medicine and Life Sciences University of Hertfordshire Hatfield United Kingdom

Department of Urology NYU Langone Health New York City NY United States

Department of Urology Tan Tock Seng Hospital Singapore Singapore

Department of Urology The University of Texas MD Anderson Cancer Center Houston TX United States

Department of Urology University College London Hospital London United Kingdom

Department of Urology University of California San Francisco San Francisco CA United States

Department of Urology University of Helsinki and Helsinki University Hospital Helsinki Finland

Department of Urology University of Texas Southwestern Dallas Texas USA

Department of Urology Weill Cornell Medical College New York New York USA

Division of Surgery and Interventional Science University College London London United Kingdom

Division of Surgery and Interventional Sciences University College London United Kingdom

Eastern Health Clinical School Monash University Box Hill Victoria Australia

European Association of Urology Young Academic Urologists Urothelial Carcinoma Working Group Arnhem Netherlands

Hourani Center for Applied Scientific Research Al Ahliyya Amman University Amman Jordan

Institute for Urology and Reproductive Health Sechenov University Moscow Russia

Lee Kong Chian School of Medicine Nanyang Technological University Singapore Singapore

Leeds Institute of Medical Research University of Leeds Leeds United Kindgom

Royal Derby Hospital University Hospitals of Derby and Burton NHS Foundation Trust Derby United Kingdom

S H Ho Urology Centre Department of Surgery Prince of Wales Hospital The Chinese University of Hong Kong Shatin Hong Kong SAR China

Sorbonne University GRC N 5 Predicitive Onco uro AP HP Hôpital Pitié Salpêtriére Paris France

Urology Department Eastern Health Box Hill Victoria Australia

Urology Unit Santa Maria della Misericordia University Hospital Udine Italy

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22031615
003      
CZ-PrNML
005      
20230127131236.0
007      
ta
008      
230119s2022 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fsurg.2022.879774 $2 doi
035    __
$a (PubMed)36268209
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Leow, Jeffrey J $u Department of Urology, Tan Tock Seng Hospital, Singapore, Singapore $u Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore
245    12
$a A systematic review and meta-analysis on delaying surgery for urothelial carcinoma of bladder and upper tract urothelial carcinoma: Implications for the COVID19 pandemic and beyond / $c JJ. Leow, WS. Tan, WP. Tan, TW. Tan, VW. Chan, KAO. Tikkinen, A. Kamat, S. Sengupta, MV. Meng, S. Shariat, M. Roupret, K. Decaestecker, N. Vasdev, YL. Chong, D. Enikeev, G. Giannarini, V. Ficarra, JY. Teoh, UroSoMe Collaborators
520    9_
$a PURPOSE: The COVID-19 pandemic has led to competing strains on hospital resources and healthcare personnel. Patients with newly diagnosed invasive urothelial carcinomas of bladder (UCB) upper tract (UTUC) may experience delays to definitive radical cystectomy (RC) or radical nephro-ureterectomy (RNU) respectively. We evaluate the impact of delaying definitive surgery on survival outcomes for invasive UCB and UTUC. METHODS: We searched for all studies investigating delayed urologic cancer surgery in Medline and Embase up to June 2020. A systematic review and meta-analysis was performed. RESULTS: We identified a total of 30 studies with 32,591 patients. Across 13 studies (n = 12,201), a delay from diagnosis of bladder cancer/TURBT to RC was associated with poorer overall survival (HR 1.25, 95% CI: 1.09-1.45, p = 0.002). For patients who underwent neoadjuvant chemotherapy before RC, across the 5 studies (n = 4,316 patients), a delay between neoadjuvant chemotherapy and radical cystectomy was not found to be significantly associated with overall survival (pooled HR 1.37, 95% CI: 0.96-1.94, p = 0.08). For UTUC, 6 studies (n = 4,629) found that delay between diagnosis of UTUC to RNU was associated with poorer overall survival (pooled HR 1.55, 95% CI: 1.19-2.02, p = 0.001) and cancer-specific survival (pooled HR of 2.56, 95% CI: 1.50-4.37, p = 0.001). Limitations included between-study heterogeneity, particularly in the definitions of delay cut-off periods between diagnosis to surgery. CONCLUSIONS: A delay from diagnosis of UCB or UTUC to definitive RC or RNU was associated with poorer survival outcomes. This was not the case for patients who received neoadjuvant chemotherapy.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Tan, Wei Shen $u Division of Surgery and Interventional Science, University College London, London, United Kingdom $u Department of Urology, University College London Hospital, London, United Kingdom
700    1_
$a Tan, Wei Phin $u Department of Urology, NYU Langone Health, New York City, NY, United States
700    1_
$a Tan, Teck Wei $u Department of Urology, Tan Tock Seng Hospital, Singapore, Singapore $u Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore
700    1_
$a Chan, Vinson Wai-Shun $u Royal Derby Hospital, University Hospitals of Derby and Burton NHS Foundation Trust, Derby, United Kingdom $u Leeds Institute of Medical Research, University of Leeds, Leeds, United Kindgom $u Division of Surgery and Interventional Sciences, University College London, United Kingdom
700    1_
$a Tikkinen, Kari A O $u Department of Urology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland $u Department of Surgery, South Karelian Central Hospital, Lappeenranta, Finland
700    1_
$a Kamat, Ashish $u Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States
700    1_
$a Sengupta, Shomik $u Urology Department, Eastern Health, Box Hill, Victoria, Australia $u Eastern Health Clinical School, Monash University, Box Hill, Victoria, Australia
700    1_
$a Meng, Maxwell V $u Department of Urology, University of California San Francisco, San Francisco, CA, United States
700    1_
$a Shariat, Shahrokh $u Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria $u Department of Urology, Weill Cornell Medical College, New York, New York, USA $u Department of Urology, University of Texas Southwestern, Dallas, Texas, USA $u Department of Urology, Second Faculty of Medicine, Charles University, Prag, Czech Republic $u Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan
700    1_
$a Roupret, Morgan $u Sorbonne University, GRC N 5, Predicitive Onco-uro, AP-HP, Hôpital Pitié-Salpêtriére, Paris, France
700    1_
$a Decaestecker, Karel $u Department of Urology, AZ Maria Middelares Hospital, Ghent, Belgium $u Department of Urology, Ghent University Hospital, Ghent, Belgium $u Department of Human Structure and Repair, Ghent University, Belgium
700    1_
$a Vasdev, Nikhil $u Department of Urology, Hertfordshire and Bedfordshire Urological Cancer Centre, Lister Hospital Stevenage, School of Medicine and Life Sciences, University of Hertfordshire, Hatfield, United Kingdom
700    1_
$a Chong, Yew Lam $u Department of Urology, Tan Tock Seng Hospital, Singapore, Singapore $u Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore
700    1_
$a Enikeev, Dmitry $u Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria $u Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia
700    1_
$a Giannarini, Gianluca $u Urology Unit, Santa Maria della Misericordia University Hospital, Udine, Italy
700    1_
$a Ficarra, Vincenzo $u Department of Human and Pediatric Pathology "Gaetano Barresi", Urologic Section, University of Messina, Messina, Italy
700    1_
$a Teoh, Jeremy Yuen-Chun $u S.H. Ho Urology Centre, Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China $u European Association of Urology - Young Academic Urologists Urothelial Carcinoma Working Group (EAU-YAU), Arnhem, Netherlands
710    2_
$a UroSoMe Collaborators
773    0_
$w MED00208008 $t Frontiers in surgery $x 2296-875X $g Roč. 9, č. - (2022), s. 879774
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36268209 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230119 $b ABA008
991    __
$a 20230127131227 $b ABA008
999    __
$a ok $b bmc $g 1889573 $s 1182948
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2022 $b 9 $c - $d 879774 $e 20221004 $i 2296-875X $m Frontiers in surgery $n Front Surg $x MED00208008
LZP    __
$a Pubmed-20230119

Najít záznam

Citační ukazatele

Možnosti archivace